Table 2.
Chimeric transcripts found in the ENCODE regions
ENCODE region | Chromosome | Gene 1 (upstream 5′) | Transcripts 1 | Promoter activity | Gene 2 (downstream 3′) | Transcripts 2 | Promoter activity | Supporting EST | RT-PCR |
---|---|---|---|---|---|---|---|---|---|
ENm009 | chr11 | TRIM6 | NM_001003818 | 45.88* | TRIM34 | NM_021616 | 242.41* | AB039903 | |
NM_058166 | (1.11 ± 1.57) | NM_130389 | (1.06 ± 1.36) | ||||||
HTC116 | MG63 | ||||||||
ENr233 | chr15 | SERF2 | NM_005770 | 929.73* | HYpk | NM_016400 | 1.88 | AK000438 | |
(1.05 ± 1.66) | (1.04 ± 1.45) | ||||||||
Be2C | Panc1 | ||||||||
ENm005 | chr21 | CRYZL1 | BC033023 | 82.11* | DONSON | NM_017613 | 9.90* | AL157441 | |
(1.19 ± 2.23) | NM_145794 | (1.19 ± 2.23) | |||||||
JEG3 | NM_145795 | JEG3 | |||||||
ENr223 | chr6 | C6orf148 | NM_030568 | 230.36* | AC019205.8-001 | AK090984 | 115.18* | BM544101 | |
bA257K9.4-002 | (1.05 ± 1.66) | (1.02 ± 1.12) | |||||||
bA257K9.4-001 | Be2C | HMCB | |||||||
ENm013 | chr7 | AC003076.1-001 | AC003076.1-001 | N/A | PFTK1 | NM_012395 | 2.43 | AF119833 | Brain |
(1.22 ± 2.43) | Liver | ||||||||
HepG2 | Colon | ||||||||
Muscle | |||||||||
Testis | |||||||||
ENr331 | chr2 | Q96IW3 | BC007201 | 2.95 | Q9H8B3 | AK023854 | 11.61* | BI559709 | Muscle |
(1.09 ± 1.41) | (1.19 ± 2.23) | BG912151 | |||||||
G402 | JEG3 | ||||||||
ENm005 | chr21 | C21orf59 | NM_021254 | 463.68* | TCP10L | NM_144659 | 1.27 | Heart | |
NM_017835 | (1.01 ± 0.74) | (1.01 ± 0.74) | |||||||
AK094456 | U87 | U87 | |||||||
AK055328 |
Tandem chimeric transcripts in the ENCODE regions supported either by ESTs or RT-PCR of computational predictions, or both. Gene and Transcript identify the genes and transcripts involved in the TICs. Supporting ESTs are the ESTs supporting the TICs after our filtering protocol (see Methods). RT-PCR lists the tissues in which expression of the chimeric transcript has been detected in the RT-PCR experiment (see Fig. 2). Experimental validation of putative promoters by reporter assay is shown on the promoter activity column. The transcription start sites were predicted by assigning the 5′ end of each gene model as the transcription start site supported by full-length cDNAs. Relative reporter activity was determined by comparing the firefly luciferase/Renilla luciferase ratios of reporter constructs in 16 different cell lines (see Trinklein et al. 2003, 2004). The highest firefly luciferase/Renilla luciferase ratios values are shown together with the mean and the standard deviation of the negative controls for the corresponding cell line. Promoter fragments with a significant reporter activity (exceeding three times the standard deviation of all control fragments) are marked with an asterisk. The firefly luciferase/Renilla luciferase ratios from the promoter regions and the negative controls were obtained from the UCSC Browser.